3 hours Aprea Therapeutics, Inc. (NASDAQ:APRE) Director Sells $29,595.96 in StockMarketBeat
Aprea Therapeutics, Inc. (NASDAQ:APRE – Get Free Report) Director Marc Duey sold 6,462 shares of the business’s stock in a transaction dated Friday, October 18th. The shares were sold at an average price of $4.58, for a total transaction of $29,595.96….
X